Document Detail


Humoral effects of long-term oral enalapril therapy.
MedLine Citation:
PMID:  3010707     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty-seven subjects with essential hypertension were prospectively followed for a minimum of 100 weeks, receiving either enalapril monotherapy or enalapril and hydrochlorothiazide combination therapy. Blood pressure and the renin-angiotensin-aldosterone system were assessed following 4 weeks of placebo therapy, and 56 and 96 weeks of maintenance drug therapy. Blood pressure was well controlled with either form of therapy. Plasma renin activity remained stimulated following both long-term monotherapy and combination therapy. However, immunoreactive plasma angiotensin II concentration was not suppressed following either long-term monotherapy or combination therapy. Similarly, plasma aldosterone concentration was not suppressed following either form of therapy; indeed, combination therapy was associated with stimulation of plasma aldosterone concentration. We conclude that enalapril monotherapy or enalapril/hydrochlorothiazide therapy was effective in controlling blood pressure, but that long-term blood pressure control must be related to an angiotensin II independent antihypertensive mechanism.
Authors:
G P Reams; J H Bauer
Related Documents :
20083287 - Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the r...
10760067 - Aldosterone and mineralocorticoid receptors: orphan questions.
3440817 - Effects of hemorrhage and naloxone on adrenal release of methionine-enkephalin and cate...
15277317 - Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients wit...
22459747 - Changes in baroreceptor sensitivity after eversion carotid endarterectomy.
18458037 - Intravascular volume administration: a contributing risk factor for intracranial hemorr...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  American journal of kidney diseases : the official journal of the National Kidney Foundation     Volume:  7     ISSN:  0272-6386     ISO Abbreviation:  Am. J. Kidney Dis.     Publication Date:  1986 May 
Date Detail:
Created Date:  1986-06-10     Completed Date:  1986-06-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8110075     Medline TA:  Am J Kidney Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  402-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Aldosterone / blood
Angiotensin II / blood
Blood Pressure / drug effects*
Blood Specimen Collection / methods
Clinical Trials as Topic
Drug Therapy, Combination
Enalapril / administration & dosage*
Humans
Hydrochlorothiazide / administration & dosage
Hypertension / drug therapy
Longitudinal Studies
Potassium / blood
Pulse / drug effects
Random Allocation
Renin / blood
Renin-Angiotensin System / drug effects*
Chemical
Reg. No./Substance:
11128-99-7/Angiotensin II; 52-39-1/Aldosterone; 58-93-5/Hydrochlorothiazide; 7440-09-7/Potassium; 75847-73-3/Enalapril; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Burkitt's cells can be triggered by teleocidin to secrete interferon-gamma.
Next Document:  A DNA probe detecting multiple haplotypes of the human Y chromosome.